High adherence to prophylaxis regimens in haemophilia B patients receiving rIX-FP: Evidence from clinical trials and real-world practice.
Maria Elisa MancusoJohannes OldenburgLisa BoggioGili KenetAnthony ChanCarmen AltisentWilfried SeifertElena SantagostinoPublished in: Haemophilia : the official journal of the World Federation of Hemophilia (2020)
In clinical studies, patients with haemophilia B had high adherence rates to rIX-FP prophylaxis regimens with a variety of dosing intervals, enabling them to achieve very low bleeding rates. High adherence may also be achievable in real-world practice.